Filed: 5/14/2024ACC: 0000950123-24-005073
📋 What this filing means
PATIENT SQUARE CAPITAL LP filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $234.83M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$234.83M
Total AUM (reported)
19.41M
Total Shares
Allocation by class
SHS$128.89M54.9%
COM NEW$105.94M45.1%
Portfolio Concentration
Top 3$234.83M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 19.41M
Sole
Full voting authority
19.41M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
ROIVANT SCIENCES LTD
SOLEShares12.23M
TypeSH
Market value$128.89M
54.89%
Sole
12.23M
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares7.18M
TypeSH
Market value$105.94M
45.11%
Sole
7.18M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTDSOLE | SHS | 12.23M | SH | $128.89M 54.89% | 12.23M | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 7.18M | SH | $105.94M 45.11% | 7.18M | 0.00 | 0.00 |